News Directory

Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at


31 October 2022

Vast Bioscience – solving the growing post-surgical pain conundrum with 3D Drug Discovery Technology

Pain is a debilitating condition and over the past few decades, escalating use of opioid therapeutics to manage pain has become a cause of concern in many countries, including Australia. Brisbane-based biotech company Vast Bioscience Pty Ltd aims to offer the pharmaceutical industry a unique opportunity to develop innovative drugs with superior potency, target selectivity and safety to help treat pain.

28 October 2022

Team Australia Wraps Up the MedTech Conference in Boston

The MTPConnect team and the 18 companies in the Australian delegation are wrapping up a week of activities at the 2022 MedTech Conference in Boston. Check out some of the top level opportunities that MTPConnect organised for these promising medtech companies.

26 October 2022

REDI Fellow Explores AI’s Powerful Role in Pathology

In Associate Professor Ewan Millar’s vision for the future of pathology in NSW, the skills, experience and expertise of Anatomical Pathologists is backed by powerful technology. A/Prof. Millar from NSW Health Pathology is currently undertaking a REDI Fellowship with Paige, a New York based global leader in AI-based diagnostic pathology software. Read about his work with Paige and his REDI Fellowship experience - an unrivalled opportunity and his dream role.

26 October 2022

MTPConnect cements US medtech links through MoU with influential Medical Alley Association at the 2022 MedTech Conference

MTPConnect and the Medical Alley Association of Minnesota have committed to working closely together to support the growth of medtech companies with the signing today of a Memorandum of Understanding. The MoU was signed at the 2022 MedTech Conference in Boston by MTPConnect Chief Executive Officer Stuart Dignam and Medical Alley Association’s Vice President of Intelligence, Frank Jaskulke.

25 October 2022

New funding for The Bridge Program to continue its successful pharma commercialisation training in 2023

The Bridge Program is proud to announce that MTPConnect’s Researcher Exchange and Development within Industry (REDI) initiative will be the new sponsor of its successful Australian pharmaceutical commercialisation training program delivered by Queensland University of Technology (QUT).

25 October 2022

Apply for GSK Australia’s Graduate Researcher Program!

The GSK Australia Graduate Researcher Program is an Australian government funded, industry-hosted initiative developed to help bridge the skills gap between academia and the pharmaceutical industry. The program aims to provide participants with a diverse range of development opportunities, hands-on experiences, and exposure, with a view to improving Australia’s success, capacity, and capability in terms of the translation and commercialisation of health and medical research. Find out more and apply for GSK's 2023 intake!

25 October 2022

Australia’s Delegation to the MedTech Conference Hits Washington and Boston

As thousands in the medical technology sector descend on Boston for the start of this week’s MedTech 2022 Conference, MTPConnect’s Australian delegation made a pre-conference visit to JLABS @ Washington, DC and joined together for a special welcome networking reception over the weekend.

21 October 2022

MTPConnect’s TTRA program invests $6.7 million to accelerate transformative Australian diabetes and cardiovascular disease innovations

MTPConnect and the Minister for Health and Aged Care, The Hon. Mark Butler MP, today announced $6.7 million funding for nine diabetes and cardiovascular disease research projects through the Targeted Translation Research Accelerator (TTRA) program.

21 October 2022

MTPConnect’s CTCM program invests $7.2 million to accelerate medical device innovations

MTPConnect and the Minister for Health and Aged Care, The Hon. Mark Butler MP, today announced $7.2 million of funding for five cutting edge medical technology projects through the Clinical Translation and Commercialisation Medtech (CTCM) program.

20 October 2022

Atmo Biosciences gas-sensing tech aims to provide user-friendly diagnostic solution for gut disorders

In 2020, gut health medtech Atmo Biosciences set out to demonstrate proof-of-concept for its gas-sensing technology – the Atmo Gas Capsule System – supported by funding from MTPConnect’s BioMedTech Horizons program.

20 October 2022

New appointment for Dr Amelia Vom

We are pleased to announce that Dr Amelia Vom has been appointed as MTPConnect’s Director of Health and Biosecurity Strategy, based in Melbourne.

19 October 2022

Australian Export Awards Announce International Health Finalists

MTPConnect is throwing its support behind the 60th Australian Export Awards in the International Health Category. The program celebrates the achievement of Australian businesses exporting home-grown innovation to the world. Find out which companies made it to the national finals.

19 October 2022

New MTPConnect Podcast: Inventia’s Skin Printing Robot Set To Revolutionise Wound Repair

Two decades after the tragic Bali bombings, we are reminded in recent news stories of many of the survivors who had to deal with devastating burns injuries and undergo skin grafts and multiple surgeries to stay alive. World renowned burns surgeon Professor Fiona Wood treated many of these burns patients and helped to develop a new technology to treat burns – a ‘spray on skin’ - now in use in over 30 countries. Professor Wood is now lending her expertise to a new project being led by Inventia Skin, a Sydney-based start-up on a mission to revolutionise wound repair.